Gender, FT4 levels, T stage, and BMI as predictors of TSH levels in thyroid cancer patients

BackgroundAfter initial treatment, levothyroxine (LT4) administration is necessary for thyroid cancer patients to achieve target thyroid-stimulating hormone (TSH) levels. However, the clinical efficacy of weight-based LT4 dosing has been suboptimal, highlighting the need to identify factors influenc...

Full description

Saved in:
Bibliographic Details
Main Authors: Sen Zhang, Shuli Niu, Ling Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1422464/full
Tags: Add Tag
No Tags, Be the first to tag this record!